Budapest, Hungary

Laszlo Otvos


Average Co-Inventor Count = 8.9

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1976-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Laszlo Otvos

Introduction

Laszlo Otvos is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with potential pharmaceutical applications. With a total of three patents to his name, Otvos continues to push the boundaries of scientific innovation.

Latest Patents

Otvos's latest patents include groundbreaking work on oligodeoxynucleotides. These compounds contain 5-alkyl and 5-(1-alkenyl) modifications, featuring a 12 to 30 nucleotide-unit long oligonucleotide that comprises at least one 5-substituted uracil or cytosine. The 5-substituent can be a C3-6 n-alkyl, a vinyl, a butenyl, an ethynyl, or a C4-12 n-1-alkynyl, with specific restrictions on the uracil moiety. Additionally, he has developed novel anticonvulsive tetrahydro-1,2,4-oxadiazine-5-thione derivatives. These compounds show promising anticonvulsive activity comparable to diphenyl hydantoine but with significantly lower toxicity.

Career Highlights

Throughout his career, Otvos has worked with esteemed organizations such as the MTA Zozponti Kemiai Kutato Intezet and Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. His work in these institutions has allowed him to collaborate with other talented scientists and contribute to important research in the field.

Collaborations

Some of his notable coworkers include Janos Sagi and Attila Szemzo. Their collaborative efforts have further advanced the research and development of innovative chemical compounds.

Conclusion

Laszlo Otvos is a distinguished inventor whose work has significantly impacted the field of chemistry. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and improving pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…